Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Operating Expenses | 8,006 | 10,629 | 8,098 | 7,989 | 7,690 |
Operating Income | -8,006 | -10,629 | -8,098 | -7,989 | -7,690 |
Interest Expense | 840 | -4,448 | 0 | 9,408 | 0 |
Other Income | 0 | -6,551 | 4,612 | 0 | 1,939 |
Pre-tax Income | -8,846 | -12,732 | -3,486 | -17,397 | -5,751 |
Net Income Continuous | -8,846 | -12,732 | -3,486 | -17,397 | -5,751 |
Net Income | $-8,846 | $-12,732 | $-3,486 | $-17,397 | $-5,751 |
EPS Basic Total Ops | -5.28 | -1.16 | -2.54 | -22.77 | -8.56 |
EPS Basic Continuous Ops | -5.40 | -0.99 | -2.36 | -22.78 | -8.67 |
EPS Diluted Total Ops | -5.28 | -1.16 | -2.54 | -22.77 | -8.56 |
EPS Diluted Continuous Ops | -5.40 | -0.99 | -2.36 | -22.78 | -8.67 |
EBITDA(a) | $-7,436 | $-9,880 | $-7,564 | $-7,469 | $-7,160 |